Caen, France – June 17, 2025 – Datexim, a leading innovator in digital pathology solutions, will promote, at the European Congress of Digital Pathology, the release of CytoProcessor® 3.3, the latest version of its CE-marked IVD device. This significant update enhances laboratory efficiency and data management for healthcare professionals. The company also proudly celebrates a major milestone: 800,000 examinations processed in clinical routine using the CytoProcessor® platform with a strong acceleration since 2024.

CytoProcessor® 3.3 introduces a suite of new features designed to streamline workflows and improve diagnostic accuracy:

· New User Interface for streamlined navigation

· Advanced Microorganism Classifier powered by deep learning

· DICOM Support and new scanner support

· Bidirectional LIS integration: LIS can now trigger actions to CytoProcessor®

· Customizable archiving management: flexible archiving policies at slide level as well as laboratory level

· Structured Reporting: All analyses for each slide, including cell classification and microorganism detection, are now consolidated into one comprehensive report.

“We are thrilled to launch CytoProcessor® 3.3, reinforcing our ongoing commitment to provide innovative solutions that empower healthcare professionals,” said Arnaud Renouf, CEO of Datexim. “These enhancements were developed in direct response to our users’ feedback, ensuring we continue addressing the evolving needs of modern cytology laboratories.”

Reflecting on Datexim’s journey, Renouf further stated, “From pioneering the world’s first IVD-certified AI tool for cervical cancer screening in 2017 to now surpassing 800,000 processed exams, we deeply appreciate our team’s dedication and the trust of our clinical partners. This milestone highlights our commitment to using artificial intelligence to deliver impactful solutions and significantly improve patient care.”

CytoProcessor® is a CE marked IVD device, intended for use by healthcare professionals only.

About Datexim: Datexim is dedicated to advancing digital pathology through innovative solutions that improve diagnostic processes and ultimately enhance patient outcomes.

Contact: Olivier Croly

Email Address – Olivier.croly@datexim.ai

Website – Datexim.ai

---

DATEXIM SAS – 24-26 rue Saint Martin – 14000 CAEN – France Siret : 529479842 – TVA : FR33529479842 – RCS CAEN Société par actions simplifiée au capital de 575 000 € Tel : +33 2 31 43 62 35 – Email : sales@datexim.ai Site internet : https:/datexim.ai